1. |
Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma \[J\]. Cancer, 1996; 77(5)∶858.
|
2. |
Takahashi Y, Bueana CD, Cleary KR, et al. p53, vessel count,and vascular endothelial growth factor expression in human colon cancer \[J\]. Int J Cancer,1998; 79(1)∶34.
|
3. |
Yoshiji H, Gomez DE, Shibuya M, et al. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer \[J\]. Cancer Res, 1996; 56(9)∶2013.
|
4. |
Porter PL, Gown AM. p53 expression in human malignant tumors \[J\]. Am J Pathol, 1992; 140(1)∶145.
|
5. |
Goh HS, Yao J, Smith DR. p53 point mutation and survival in colorectal cancer patients \[J\]. Cancer Res, 1995; 55(22)∶5217.
|
6. |
Yamamura T, Matsuzaki H, Suda T, et al. Clinicopathological variables and p53 overexpression as a combined prognosticator for hematogenic recurrence in colorectal cancer \[J\]. J Surg Oncol, 1999; 70(1)∶1.
|
7. |
Kieser A, Weich HA, Brandner G, et al. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression \[J\]. Oncogene, 1994; 9(3)∶963.
|
8. |
Steele RJC, Thompson AM, Hall PA, et al. The p53 tumour suppressor gene \[J\]. Br J Surg, 1998; 85(11)∶1460.
|